Keywords: USA, Generics market, PPIs, RNCOS

US generics market, worth $74 billion in 2009, set to grow at 10% CAGR

Article | 14 July 2011

The US generics market has shown a solid growth during the past few years backed by factors, such as government ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in